BRCA Mutations in Cancer: Implications for Tumor Biology, Surveillance, and TreatmentView this Special Issue
Corrigendum | Open Access
Noa Harpaz, Yair Eli Gatt, Roy Zvi Granit, Hila Fruchtman, Ayala Hubert, Albert Grinshpun, "Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”", Journal of Oncology, vol. 2020, Article ID 6725209, 1 page, 2020. https://doi.org/10.1155/2020/6725209
Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”
In the article titled “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer” , some information was omitted in the Acknowledgments section, which should be corrected as follows:
This study was kindly supported by the Ministry of Science and Technology Personalized Medicine Grant. Y.E. Gatt was partially supported by the Hoffman Program. The authors would like to thank T. Bdolah-Abram from the Hebrew University of Jerusalem for her help with the statistical analysis. The study was conducted as part of the requirements for a Noa Harpaz’s M.D. certificate in the Faculty of Medicine, the Hebrew University of Jerusalem.
- N. Harpaz, Y. E. Gatt, R. Z. Granit, H. Fruchtman, A. Hubert, and A. Grinshpun, “Mucinous histology, BRCA1/2 mutations, and elevated tumor mutational burden in colorectal cancer,” Journal of Oncology, vol. 2020, Article ID 6421205, 10 pages, 2020.
Copyright © 2020 Noa Harpaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.